98%
921
2 minutes
20
Objective: To determine and ascertain factors influencing seizure control and maternal and neonatal outcomes in women with epilepsy (WWE) with planned versus unplanned pregnancies.
Methods: One hundred twelve pregnant WWE were prospectively evaluated for over an eight-year period. Patients were subsequently evaluated at 3, 6, and 12 months after delivery and then were followed up by a neurologist at least three years after delivery.
Results: The proportion of the patients with increased seizure frequency was higher in focal epilepsy versus generalized epilepsy (P<0.05). The occurrence of seizures during pregnancy was associated with poor seizure control one year prior to the pregnancy and nonadherence to treatment (P<0.0001). Structural brain abnormalities were associated with a higher risk of seizures during pregnancy (P=0.03). Women with seizures during pregnancy (P=0.0069) and with non-adherence to antiseizure medication (ASM) treatment had a higher rate of cesarean section (P=0.0069 and P<0.05, respectively). The rates of adverse delivery outcomes were not higher in women with planned pregnancies compared to women with unplanned pregnancies. However, offspring of mothers with unplanned pregnancies and nonadherence to treatment were at higher risk of an Apgar score at 5minutes≤7 compared with infants of planned pregnancies (P=0.02 and P=0.0001, respectively).
Conclusion: Seizure control prior to pregnancy, epilepsy type, adherence to ASM therapy, and pregnancy planning are potential factors influencing both seizure control and delivery outcomes in WWE. Our findings imply that systematic preconception counseling is crucial to preventing seizure deterioration in pregnancy and reducing the maternal and fetal complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neurol.2025.07.006 | DOI Listing |
Front Med (Lausanne)
August 2025
Genomics Laboratory, Institute of Translational Medicine Pirogov Russian National Research Medical University, Moscow, Russia.
Neuronal ceroid lipofuscinosis (NCL) is one of the most common causes of childhood dementia. NCL type 5 is characterized by epileptic seizures, cognitive decline, and progressive vision loss. Whole exome sequencing was performed, and the identified variant was confirmed by Sanger sequencing.
View Article and Find Full Text PDFCureus
August 2025
Psychiatry and Behavioral Sciences, West Virginia University, Morgantown, USA.
This study examined whether caregivers of male or female patients with epilepsy differ in perceived burden, social support, and coping mechanisms. In a cross-sectional design conducted at a tertiary neuropsychiatric hospital, 60 caregivers (30 per group) completed the Family Burden Interview Schedule (FBIS), the Social Support Questionnaire (SSQ), and the Ways of Coping Questionnaire (WCQ). Caregivers of female patients reported greater financial strain and more pronounced impacts on mental and physical health, yet they also perceived higher levels of social support.
View Article and Find Full Text PDFACS Chem Neurosci
September 2025
Department of Bioengineering, Rice University, Houston, Texas 77030, United States.
Many neurological and psychiatric diseases are characterized by pathological neuronal activity. Current treatments involve drugs, surgeries, and implantable devices to modulate or remove the affected region. However, none of these methods can be simultaneously nonsurgical and possess site- and cell type specificity.
View Article and Find Full Text PDFJ Neural Eng
September 2025
University of Pennsylvania, 3400 Spruce Street, Philadelphia, Pennsylvania, 19104-6243, UNITED STATES.
New implantable and wearable devices hold great promise to help patients manage their seizure disorders. One proposed application is measuring the rate of interictal epileptiform discharges as a biomarker of medication levels and seizure risk. This study aims to determine whether interictal epileptiform spike rates (spikes) are independently associated with anti-seizure medication (ASM) levels and evaluate whether spike rates are a reliable biomarker for ASM levels.
View Article and Find Full Text PDFJCI Insight
September 2025
Department of Physiology and Neurobiology, University of Connecticut, Storrs, United States of America.
Dravet syndrome (DS) is an early-onset epilepsy caused by loss of function mutations in the SCN1A gene, which encodes Nav1.1 channels that preferentially regulate activity of inhibitory neurons early in development. DS is associated with a high incidence of sudden unexpected death in epilepsy (SUDEP) by a mechanism that may involve respiratory failure.
View Article and Find Full Text PDF